Provider
P30-16 New Prior Authorization Requirement for Lyme Disease: Diagnostic Testing and Intravenous Antibiotic Therapy
Program effective Date: Jul 07, 2016
Search Results
Displaying 3261 - 3270 of 3661 results
Provider
P14-16 Addition of Lazanda ® to Existing Drug-Related Prior Authorization with Quantity Limit Program
Program effective Date: Mar 29, 2016
Provider
P49-16 New Drug-Related Prior Authorization Criteria with Quantity Limit for Zavesca
Program effective Date: Oct 27, 2016
Provider
P24-16 Providers will see a change in our Prior Authorization Process for Government Products
Program effective Date: Jun 01, 2016
Provider
P7-16 Addition of Drugs to the Self-Administered Oral Oncology Prior Authorization with Quantity Limit Program
Program effective Date: Jan 27, 2016
Provider
P5-17 Updated: Third Party Payments of Premium and/or Cost-Sharing
Program effective Date: Feb 08, 2017
Provider
P8-16 Personal Care Assistance (PCA) Service UMPI Delay Process
Program effective Date: Feb 08, 2016
Provider
P28R2-16 Revised: Elimination of Prior Authorization Requirements for Select Services for Government Programs
Program effective Date: Aug 09, 2016
Provider
P26-16 Update to Billing Guidelines for Refence and Outside Lab Services for Minnesota Health Care Programs (MHCP) Subscribers
Program effective Date: Jun 07, 2016
Provider
P7-17 Drug-Related Prior Authorization for Growth Hormone
Program effective Date: Mar 06, 2017